Skip to Main Content

Paper Details

Development of a clinical polygenic risk score assay and reporting workflow.
Nat Med
61
2022
PRS, breast cancer, colorectal cancer, diabetes, participants, patient, patients, prostate cancer
Author NameAffiliation
Peter KraftHarvard T.H. Chan School of Public Health
Peter KraftHarvard T.H. Chan School of Public Health
Gabriel F Berriz
Robert C GreenHarvard Medical School
Robert C GreenBroad Institute of Harvard and the Massachusetts Institute of Technology
Robert C GreenBrigham and Women's Hospital
Robert C Green
Anna C F LewisE J Safra Center for Ethics, Harvard University
Steven A LubitzBroad Institute of Harvard and the Massachusetts Institute of Technology
Steven A LubitzDemoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital
Steven A LubitzCardiovascular Research Center, Massachusetts General Hospital
Steven A LubitzBroad Institute of Harvard and the Massachusetts Institute of Technology
Steven A LubitzCardiovascular Research Center, Massachusetts General Hospital
Steven A LubitzDemoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital
Pradeep NatarajanHarvard Medical School
Pradeep NatarajanCardiovascular Research Center, Massachusetts General Hospital
Pradeep NatarajanBroad Institute of Harvard and the Massachusetts Institute of Technology
Matthew S Lebo
Matthew S LeboHarvard Medical School
Matthew S LeboBrigham and Women's Hospital
  • 1 - 20

Datasets